![](/img/cover-not-exists.png)
Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial
Haidar, Ahmad, Messier, Virginie, Legault, Laurent, Ladouceur, Martin, Rabasa-Lhoret, RémiVolume:
19
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12880
Date:
May, 2017
File:
PDF, 1.19 MB
english, 2017